Parkinson's disease [NEW TOPIC PAGE]

Main|Search|PHGKB

A common culprit in Parkinson’s disease? A fluorescent sensor for LRRK2 activity reveals the protein may be involved in many cases of Parkinson’s diseaseGreenamyre lab




Last Posted: Nov 08, 2018

---

• Largest genome-wide association study for PTSD identifies genetic risk loci in European and African ancestries and implicates novel biological pathways
  BioRXIV preprints, November 1, 2018
• Pharmacogenetics and levodopa induced motor complications.
  Kalinderi Kallirhoe et al. The International journal of neuroscience 2018 Oct 1-31
• Recent Advances in Biomarkers for Parkinson's Disease.
  He Runcheng et al. Frontiers in aging neuroscience 2018 10305
• Mendelian Randomization Studies of Coffee and Caffeine Consumption.
  Cornelis Marilyn C et al. Nutrients 2018 Sep 10(10)
• Pharmacogenomics of Alzheimer's and Parkinson's diseases.
  Cacabelos Ramón et al. Neuroscience letters 2018 Sep
• Decoding Your DNA: What to Consider Before Genetic Testing
  K Hobson, US News, September, 2018
• [FROM GENETICS OF FRAGILE X SYNDROME TO DEVELOPMENT OF TARGETED AND PERSONALIZED DRUG THERAPY].
  Gabis Lidia V et al. Harefuah 2018 Aug 157(8) 529-533
• Self-report data as a tool for subtype identification in genetically-defined Parkinson's Disease.
  Winslow Ashley R et al. Scientific reports 2018 Aug 8(1) 12992
• Finding useful biomarkers for Parkinson's disease.
  Chen-Plotkin Alice S et al. Science translational medicine 2018 Aug 10(454)
• What Personal Genome Testing Can and Can't Do-The limitations of personal genome service testing 
  M Shermer, Scientific American, August 2018

more